205 related articles for article (PubMed ID: 10354716)
1. [Extracellular components of broncho-alveolar lavage fluid (BALF) as markers of interstitial pulmonary disease activity. II. Phospholipid concentration].
Zielonka TM; Wałajtys-Rode E; Jasińska R; Chazan R; Droszcz W
Przegl Lek; 1998; 55(12):654-8. PubMed ID: 10354716
[TBL] [Abstract][Full Text] [Related]
2. [Extracellular components of bronchoalveolar lavage fluid (BALF) as a marker of the activity of interstitial pulmonary diseases. III: Phospholipids to protein concentration ratio].
Zielonka TM; Wałajtys-Rode E; Jasińska R; Chazan R; Droszcz W
Przegl Lek; 1999; 56(2):144-7. PubMed ID: 10375948
[TBL] [Abstract][Full Text] [Related]
3. [Extracellular components of bronchoalveolar lavage fluid (BALF) as a marker of interstitial pulmonary disease activity. I. Protein concentration].
Zielonka TM; Wałajtys-Rode E; Chazan R; Droszcz W
Przegl Lek; 1998; 55(11):581-5. PubMed ID: 10216371
[TBL] [Abstract][Full Text] [Related]
4. [Concentration of thromboxane B2 in bronchoalveolar lavage fluid in selected interstitial pulmonary diseases].
Zielonka TM; Rybus L; Doboszyńska A; Wałajtys-Rode E; Walkiewicz R; Droszcz W
Przegl Lek; 1995; 52(6):315-7. PubMed ID: 7568987
[TBL] [Abstract][Full Text] [Related]
5. A comparison of albumin and urea as reference markers in bronchoalveolar lavage fluid from patients with interstitial lung disease.
Jones KP; Edwards JH; Reynolds SP; Peters TJ; Davies BH
Eur Respir J; 1990 Feb; 3(2):152-6. PubMed ID: 2311740
[TBL] [Abstract][Full Text] [Related]
6. Elevated matrilysin levels in bronchoalveolar lavage fluid do not distinguish idiopathic pulmonary fibrosis from other interstitial lung diseases.
Vuorinen K; Myllärniemi M; Lammi L; Piirilä P; Rytilä P; Salmenkivi K; Kinnula VL
APMIS; 2007 Aug; 115(8):969-75. PubMed ID: 17696954
[TBL] [Abstract][Full Text] [Related]
7. [Concentration of sialic acid in bronchoalveolar lavage fluid in selected interstitial pulmonary diseases].
Zielonka TM; Lasota A; Wałajtys-Rode E; Droszcz P; Chazan R
Pneumonol Alergol Pol; 1995; 63(11-12):627-31. PubMed ID: 8616478
[TBL] [Abstract][Full Text] [Related]
8. Bronchoalveolar lavage fluid protein composition in patients with sarcoidosis and idiopathic pulmonary fibrosis: a two-dimensional electrophoretic study.
Magi B; Bini L; Perari MG; Fossi A; Sanchez JC; Hochstrasser D; Paesano S; Raggiaschi R; Santucci A; Pallini V; Rottoli P
Electrophoresis; 2002 Sep; 23(19):3434-44. PubMed ID: 12373774
[TBL] [Abstract][Full Text] [Related]
9. Chitotriosidase activity in patients with interstitial lung diseases.
Bargagli E; Margollicci M; Luddi A; Nikiforakis N; Perari MG; Grosso S; Perrone A; Rottoli P
Respir Med; 2007 Oct; 101(10):2176-81. PubMed ID: 17631992
[TBL] [Abstract][Full Text] [Related]
10. [A study on enzymatic activities of bronchoalveolar lavage fluid in patients with interstitial lung diseases].
Zheng J; Jia Y; Zhou K
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Feb; 21(2):91-3. PubMed ID: 11263392
[TBL] [Abstract][Full Text] [Related]
11. Increased endothelin-1 levels of BAL fluid in patients with pulmonary sarcoidosis.
Terashita K; Kato S; Sata M; Inoue S; Nakamura H; Tomoike H
Respirology; 2006 Mar; 11(2):145-51. PubMed ID: 16548898
[TBL] [Abstract][Full Text] [Related]
12. Induced sputum in patients with interstitial lung disease: a non-invasive surrogate for certain parameters in bronchoalveolar lavage fluid.
Sobiecka M; Kus J; Demkow U; Filewska M; Jozwik A; Radwan-Rohrenschef P; Chorostowska-Wynimko J
J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():645-57. PubMed ID: 19218691
[TBL] [Abstract][Full Text] [Related]
13. [Concentration of alkaline phosphatase (AP) and AP/albumin ratio in bronchoalveolar lavage (BAL) for the diagnosis of interstitial lung diseases].
Schildge J; Klar B; Weinstock N
Pneumologie; 2000 Sep; 54(9):385-91. PubMed ID: 11072722
[TBL] [Abstract][Full Text] [Related]
14. NTP Toxicology and Carcinogenesis Studies of Talc (CAS No. 14807-96-6)(Non-Asbestiform) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 421():1-287. PubMed ID: 12616290
[TBL] [Abstract][Full Text] [Related]
15. Different expression of endothelin in the bronchoalveolar lavage in patients with pulmonary diseases.
Reichenberger F; Schauer J; Kellner K; Sack U; Stiehl P; Winkler J
Lung; 2001; 179(3):163-74. PubMed ID: 11891606
[TBL] [Abstract][Full Text] [Related]
16. [KL-6 in patients with interstitial pneumonitis].
Hamada H; Sakatani M; Ueda E
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Jul; 34(7):771-7. PubMed ID: 8810758
[TBL] [Abstract][Full Text] [Related]
17. [The state of the protease-inhibitor system in the bronchoalveolar lavage of patients with diffuse lung diseases].
Kaminskaia GO; Stepanian IE; Zhukova NL
Vopr Med Khim; 1988; 34(6):100-4. PubMed ID: 3070930
[TBL] [Abstract][Full Text] [Related]
18. [Role of alveolar macrophages in the pathogenesis of idiopathic interstitial pneumonia].
Suga M; Iyonaga K; Ando M
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():175-80. PubMed ID: 9216211
[TBL] [Abstract][Full Text] [Related]
19. Effect of transportation on the composition of bronchoalveolar lavage fluid obtained from horses.
Hobo S; Oikawa M; Kuwano A; Yoshida K; Yoshihara T
Am J Vet Res; 1997 May; 58(5):531-4. PubMed ID: 9140563
[TBL] [Abstract][Full Text] [Related]
20. [Mast cells in bronchoalveolar lavage fluid of patients with interstitial lung diseases].
Schildge J; Klar B; Hardung-Backes M
Pneumologie; 2003 Apr; 57(4):202-7. PubMed ID: 12690558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
